Literature DB >> 29739791

ΔNp63γ/SRC/Slug Signaling Axis Promotes Epithelial-to-Mesenchymal Transition in Squamous Cancers.

Simon S McDade1, Dennis J McCance2, Kirtiman Srivastava1, Adam Pickard3,4, Stephanie G Craig3, Gerard P Quinn3, Shauna M Lambe3, Jacqueline A James3.   

Abstract

Purpose: To investigate the regulation of epithelial-to-mesenchymal transition (EMT) in head and neck squamous cell carcinoma (HNSCC) and its importance in tumor invasion.Experimental Design: We use a three-dimensional invasive organotypic raft culture model of human foreskin keratinocytes expressing the E6/E7 genes of the human papilloma virus-16, coupled with bioinformatic and IHC analysis of patient samples to investigate the role played by EMT in invasion and identify effectors and upstream regulatory pathways.
Results: We identify SNAI2 (Slug) as a critical effector of EMT-activated downstream of TP63 overexpression in HNSCC. Splice-form-specific depletion and rescue experiments further identify the ΔNp63γ isoform as both necessary and sufficient to activate the SRC signaling axis and SNAI2-mediated EMT and invasion. Moreover, elevated SRC levels are associated with poor outcome in patients with HNSCC in The Cancer Genome Atlas dataset. Importantly, the effects on EMT and invasions and SNAI2 expression can be reversed by genetic or pharmacologic inhibition of SRC.Conclusions: Overexpression of ΔNp63γ modulates cell invasion by inducing targetable SRC-Slug-evoked EMT in HNSCC, which can be reversed by inhibitors of the SRC signaling. Clin Cancer Res; 24(16); 3917-27. ©2018 AACR. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29739791      PMCID: PMC6098695          DOI: 10.1158/1078-0432.CCR-17-3775

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  47 in total

1.  p63 maintains keratinocyte proliferative capacity through regulation of Skp2-p130 levels.

Authors:  Simon S McDade; Daksha Patel; Dennis J McCance
Journal:  J Cell Sci       Date:  2011-04-21       Impact factor: 5.285

2.  Role of DeltaNp63gamma in epithelial to mesenchymal transition.

Authors:  Jaime Lindsay; Simon S McDade; Adam Pickard; Karen D McCloskey; Dennis J McCance
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

3.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

4.  The SLUG zinc-finger protein represses E-cadherin in breast cancer.

Authors:  Karen M Hajra; David Y-S Chen; Eric R Fearon
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

5.  Angiotensin II type 2 receptor-interacting protein 3a suppresses proliferation, migration and invasion in tongue squamous cell carcinoma via the extracellular signal-regulated kinase-Snai2 pathway.

Authors:  Tingting Zhao; Qianting He; Zhonghua Liu; Xueqiang Ding; Xiaofeng Zhou; Anxun Wang
Journal:  Oncol Lett       Date:  2015-11-10       Impact factor: 2.967

6.  P63 regulates tubular formation via epithelial-to-mesenchymal transition.

Authors:  Y Zhang; W Yan; X Chen
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

7.  ERalpha signaling through slug regulates E-cadherin and EMT.

Authors:  Y Ye; Y Xiao; W Wang; K Yearsley; J X Gao; B Shetuni; S H Barsky
Journal:  Oncogene       Date:  2010-01-18       Impact factor: 9.867

8.  ΔNp63α induces the expression of FAT2 and Slug to promote tumor invasion.

Authors:  Tuyen T Dang; Jill M Westcott; Erin A Maine; Mohammed Kanchwala; Chao Xing; Gray W Pearson
Journal:  Oncotarget       Date:  2016-05-10

9.  AKT in stromal fibroblasts controls invasion of epithelial cells.

Authors:  Ann-Christin Cichon; Adam Pickard; Simon S McDade; Daniel J Sharpe; Michael Moran; Jacqueline A James; Dennis J McCance
Journal:  Oncotarget       Date:  2013-07

10.  Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation.

Authors:  Simon S McDade; Alexandra E Henry; Geraldine P Pivato; Iwanka Kozarewa; Constantinos Mitsopoulos; Kerry Fenwick; Ioannis Assiotis; Jarle Hakas; Marketa Zvelebil; Nicholas Orr; Christopher J Lord; Daksha Patel; Alan Ashworth; Dennis J McCance
Journal:  Nucleic Acids Res       Date:  2012-05-09       Impact factor: 16.971

View more
  4 in total

1.  Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide.

Authors:  Ping Lu; Shai White-Gilbertson; Rose Nganga; Mark Kester; Christina Voelkel-Johnson
Journal:  Cancer Biol Ther       Date:  2019-03-05       Impact factor: 4.742

2.  Slug and Vimentin downregulation at the metastatic site is associated with Skip-N2 metastasis of lung adenocarcinoma.

Authors:  Yasemin Saygideger; Alper Avci; Emine Bagir; Burcu Saygıdeğer Demir; Aycan Sezan; Mucahit Ekici; Oya Baydar; Özgür Cem Erkin
Journal:  Discov Oncol       Date:  2022-01-22

3.  Combined treatment with N-acetylcysteine and gefitinib overcomes drug resistance to gefitinib in NSCLC cell line.

Authors:  Jun Li; Xiao-Hui Wang; Jing Hu; Meng Shi; Lu Zhang; Hong Chen
Journal:  Cancer Med       Date:  2019-12-31       Impact factor: 4.452

4.  A proteogenomic portrait of lung squamous cell carcinoma.

Authors:  Shankha Satpathy; Karsten Krug; Pierre M Jean Beltran; Sara R Savage; Francesca Petralia; Chandan Kumar-Sinha; Yongchao Dou; Boris Reva; M Harry Kane; Shayan C Avanessian; Suhas V Vasaikar; Azra Krek; Jonathan T Lei; Eric J Jaehnig; Tatiana Omelchenko; Yifat Geffen; Erik J Bergstrom; Vasileios Stathias; Karen E Christianson; David I Heiman; Marcin P Cieslik; Song Cao; Xiaoyu Song; Jiayi Ji; Wenke Liu; Kai Li; Bo Wen; Yize Li; Zeynep H Gümüş; Myvizhi Esai Selvan; Rama Soundararajan; Tanvi H Visal; Maria G Raso; Edwin Roger Parra; Özgün Babur; Pankaj Vats; Shankara Anand; Tobias Schraink; MacIntosh Cornwell; Fernanda Martins Rodrigues; Houxiang Zhu; Chia-Kuei Mo; Yuping Zhang; Felipe da Veiga Leprevost; Chen Huang; Arul M Chinnaiyan; Matthew A Wyczalkowski; Gilbert S Omenn; Chelsea J Newton; Stephan Schurer; Kelly V Ruggles; David Fenyö; Scott D Jewell; Mathangi Thiagarajan; Mehdi Mesri; Henry Rodriguez; Sendurai A Mani; Namrata D Udeshi; Gad Getz; James Suh; Qing Kay Li; Galen Hostetter; Paul K Paik; Saravana M Dhanasekaran; Ramaswamy Govindan; Li Ding; Ana I Robles; Karl R Clauser; Alexey I Nesvizhskii; Pei Wang; Steven A Carr; Bing Zhang; D R Mani; Michael A Gillette
Journal:  Cell       Date:  2021-08-05       Impact factor: 66.850

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.